Inactive Instrument

All News Isleworth Healthcare Acquisition Corp. Nasdaq

Equities

ISLE.U

US46468P2011

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

ISLEWORTH HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	22-08-26	AQ
Isleworth Healthcare Acquisition to Dissolve, Delist After Failing to Combine Business by Sept. 1	22-08-26	MT
Isleworth Healthcare Acquisition Corp.(NasdaqCM:ISLE) dropped from NASDAQ Composite Index	22-08-26	CI
Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution	22-08-25	PR
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-12	AQ
Isleworth Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Blank Check Firm Isleworth Healthcare Acquisition, Cytovia Scrap Merger Deal	22-06-30	MT
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT	22-06-30	PR
Isleworth Healthcare Acquisition : AND CYTOVIA TERMINATE MERGER AGREEMENT - Form 8-K	22-06-30	PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-06-30	AQ
Cytovia Therapeutics, Inc. cancelled the acquisition of Isleworth Healthcare Acquisition Corp. from Isleworth Healthcare Sponsor I, LLC and others in a reverse merger transaction.	22-06-29	CI
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-06-24	AQ
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22-06-10	AQ
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress	22-06-10	PR
Isleworth Healthcare Acquisition : Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer - Form 8-K	22-06-07	PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-06-06	AQ
Isleworth Healthcare Acquisition : Quarterly Report (Form 10-Q)	22-05-23	PU
Isleworth Healthcare Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-23	AQ
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 Congress	22-05-18	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Isleworth Healthcare Acquisition Corp. Nasdaq

Equities

ISLE.U

US46468P2011

All News

Filters